BR9907967A - Composto de polipeptideo, processo para sua preparação, composição farmacêutica compreendendo dito composto, e seu uso. - Google Patents

Composto de polipeptideo, processo para sua preparação, composição farmacêutica compreendendo dito composto, e seu uso.

Info

Publication number
BR9907967A
BR9907967A BR9907967-4A BR9907967A BR9907967A BR 9907967 A BR9907967 A BR 9907967A BR 9907967 A BR9907967 A BR 9907967A BR 9907967 A BR9907967 A BR 9907967A
Authority
BR
Brazil
Prior art keywords
compound
preparation
pharmaceutical composition
polypeptide
pneumocystis carinii
Prior art date
Application number
BR9907967-4A
Other languages
English (en)
Inventor
Hidenori Ohki
Kenji Murano
Takashi Tojo
Nobuyuki Shiraishi
Takahiro Matsuya
Hiroshi Matsuda
Hiroaki Mizuno
David Barrett
Keiji Matsuda
Kohji Kawabata
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP1728A external-priority patent/AUPP172898A0/en
Priority claimed from AUPP3138A external-priority patent/AUPP313898A0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR9907967A publication Critical patent/BR9907967A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSTO DE POLIPEPTìDEO, PROCESSO PARA SUA PREPARAçãO, COMPOSIçãO FARMACêUTICA COMPREENDENDO DITO COMPOSTO, E SEU USO". A presente invenção refere-se a novos compostos de polipeptídeo representados pela fórmula geral (I), onde R^ 1^, R^ 2^, R^ 3^e R^ 4^ são conforme definidos na descrição, ou um sal dos mesmos apresentando atividades antimicrobianas (especialmente atividades antifúngicas), atividade inibidora da sintase de <225>-1, 3-glucano, a um processo para sua preparação a uma composição farmacêutica compreendendo o mesmo, e a um método para o tratamento profilático e/ou terapêutico de doenças infecciosas, inclusive infecção por <MU> Pneumocystis carinii <MV> (ex: pneumonia causada por <MU> Pneumocystis carinii <MV>) num ser humano ou animal.
BR9907967-4A 1998-02-09 1999-02-05 Composto de polipeptideo, processo para sua preparação, composição farmacêutica compreendendo dito composto, e seu uso. BR9907967A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP1728A AUPP172898A0 (en) 1998-02-09 1998-02-09 New compound
AUPP3138A AUPP313898A0 (en) 1998-04-23 1998-04-23 New compound
PCT/JP1999/000538 WO1999040108A1 (en) 1998-02-09 1999-02-05 New compound

Publications (1)

Publication Number Publication Date
BR9907967A true BR9907967A (pt) 2000-10-17

Family

ID=25645713

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9907967-4A BR9907967A (pt) 1998-02-09 1999-02-05 Composto de polipeptideo, processo para sua preparação, composição farmacêutica compreendendo dito composto, e seu uso.

Country Status (13)

Country Link
US (1) US6232290B1 (pt)
EP (1) EP1053247A1 (pt)
JP (2) JP3561917B2 (pt)
KR (1) KR100396737B1 (pt)
CN (1) CN1240713C (pt)
AR (1) AR014554A1 (pt)
BR (1) BR9907967A (pt)
CA (1) CA2320416A1 (pt)
HU (1) HUP0102515A3 (pt)
IL (1) IL137494A0 (pt)
NO (1) NO20003996L (pt)
TR (1) TR200003064T2 (pt)
WO (1) WO1999040108A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2270819T3 (es) * 1999-03-03 2007-04-16 Eli Lilly And Company Formacion e intercambio anionico de sales de amonio internas cristalinas de equinocandina.
AUPP999799A0 (en) 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
TWI250992B (en) 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
US7208503B2 (en) * 2000-04-21 2007-04-24 Janssen Pharmaceutica N.V. Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
US6316475B1 (en) * 2000-11-17 2001-11-13 Abbott Laboratories Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications
AUPR362001A0 (en) * 2001-03-08 2001-04-05 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPS044102A0 (en) * 2002-02-11 2002-03-07 Fujisawa Pharmaceutical Co., Ltd. New compound
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
AU2003903629A0 (en) * 2003-07-14 2003-07-31 Fujisawa Pharmaceutical Co., Ltd. New compound
EP3067053A1 (en) * 2004-10-13 2016-09-14 PTC Therapeutics, Inc. Compounds for nonsense suppression, and methods for their use
CA2610310A1 (en) * 2005-06-08 2006-12-14 Novartis Ag Polycyclic oxadiazoles or isoxazoles and their use as s1p receptor ligands
CA2613458A1 (en) * 2005-07-12 2007-01-18 Acadia Pharmaceuticals Inc. Compounds with activity at retinoic acid receptors
JP2009501199A (ja) * 2005-07-12 2009-01-15 グラクソ グループ リミテッド Ｇｐｒ３８アゴニストとしてのピペラジンヘテロアリール誘導体
KR20080066938A (ko) * 2005-10-07 2008-07-17 깃세이 야쿠힌 고교 가부시키가이샤 질소 함유 복소환 화합물 및 그것을 함유하는 의약 조성물
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
EP2947080B1 (en) 2007-08-13 2017-10-25 Monsanto Technology LLC Compositions and methods for controlling nematodes
KR20100075892A (ko) 2007-10-29 2010-07-05 아스테라스 세이야쿠 가부시키가이샤 폴리펩티드 화합물
CN101970462B (zh) 2008-03-14 2013-06-19 安斯泰来制药株式会社 环状化合物及其盐
WO2010081851A1 (en) 2009-01-14 2010-07-22 Genoscience Pharma Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
JPWO2010131691A1 (ja) * 2009-05-14 2012-11-01 アステラス製薬株式会社 ポリケチド化合物
US9353072B2 (en) * 2012-10-31 2016-05-31 Purdue Research Foundation Antimicrobial substituted thiazoles and methods of use
WO2019207413A1 (en) 2018-04-25 2019-10-31 Universidad De La República (Udelar) Cyclic hexapeptides compounds with anti-malarial activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI912873A (fi) 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
IL109615A (en) * 1993-05-17 2000-12-06 Fujisawa Pharmaceutical Co Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
MX9702531A (es) * 1994-10-07 1997-06-28 Fujisawa Pharmaceutical Co Compuesto nuevo.
US5629289A (en) * 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents

Also Published As

Publication number Publication date
EP1053247A1 (en) 2000-11-22
HUP0102515A2 (hu) 2001-11-28
TR200003064T2 (tr) 2001-02-21
AR014554A1 (es) 2001-02-28
NO20003996D0 (no) 2000-08-08
CA2320416A1 (en) 1999-08-12
WO1999040108A1 (en) 1999-08-12
JP2001522377A (ja) 2001-11-13
KR100396737B1 (ko) 2003-09-13
CN1240713C (zh) 2006-02-08
CN1296494A (zh) 2001-05-23
IL137494A0 (en) 2001-07-24
US6232290B1 (en) 2001-05-15
NO20003996L (no) 2000-10-09
JP2004067699A (ja) 2004-03-04
JP3561917B2 (ja) 2004-09-08
HUP0102515A3 (en) 2001-12-28

Similar Documents

Publication Publication Date Title
BR9907967A (pt) Composto de polipeptideo, processo para sua preparação, composição farmacêutica compreendendo dito composto, e seu uso.
MX9702531A (es) Compuesto nuevo.
BRPI0412527A (pt) composto, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica, e, processo para preparar um composto.
ES2237160T3 (es) Composiciones antimicrobianas dermicas topicas.
BR0210344A (pt) Inibidores da hiv protease, composições contendo os mesmos, seus usos farmacêuticos e materiais para a sua sìntese
BR0209271A (pt) Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
BRPI0415613A (pt) novos compostos de diazaspiroalcanos e seu uso no tratamento de doenças mediadas por ccr8
DE60004803D1 (de) Pulmonare abgabe von protonierter/angesäuerter nukleinsäure
HUP0004423A2 (hu) Acil-szulfamoil-benzoesav-amidok, az ezeket tartalmazó haszonnövényvédő készítmények és eljárás az előállításukra
CA2964244A1 (en) An antimicrobial composition
BR9712202A (pt) Composto, processo para preparar o mesmo, composicão farmacêutica, processo para o tratamento de inflamacão neurogênica em um indivíduo em necessidade deste tratamento, e, uso do composto.
Slobodníková et al. Rosmarinic acid interaction with planktonic and biofilm Staphylococcus aureus
BRPI0013010B8 (pt) formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
BR0309498A (pt) Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças que são relacionadas com o ras, e, uso de compostos
Min et al. Antibacterial and antibiofilm activities of a novel synthetic cyclic lipopeptide against cariogenic Streptococcus mutans UA159
BR9813651A (pt) Compostos antipicornavirais e métodos para o seu uso e preparação
BR9813536A (pt) &#34;derivados oxima e produtos quìmicos agrìcolas incluindo os mesmos&#34;
BR0016051A (pt) ésteres clorofìlicos e bacterioclorofìlicos, sua preparação e composições farmacêuticas que os compreendem
BR9915480A (pt) Azalìdeos de 13 membros e a sua utilização como agentes antibióticos
JPH021806B2 (pt)
WO2002072621A3 (en) Cyclohexapeptide having antimicrobial activity
BR9813317A (pt) Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto
BR0211635A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um indivìduo sofrendo de ou propenso à doença de alzheimer
BR0108792A (pt) Composto de polipeptìdeo, processo para sua preparação, composição farmacêutica contendo o mesmo, seu uso, método, embalagem comercial e artigo de manufatura
Kameri et al. Antibacterial effect of Matricaria chamomilla L. Extract against Enterococcus faecalis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A,9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1990 DE 25/02/2009.